These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3040227)

  • 1. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.
    Meijer C; Mulder NH; Timmer-Bosscha H; Zijlstra JG; de Vries EG
    Cancer Res; 1987 Sep; 47(17):4613-7. PubMed ID: 3040227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.
    Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1987 Apr; 47(7):1780-4. PubMed ID: 3028613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
    de Jong S; Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA; Mulder NH; de Jong B; de Ley L; Uges DR; Fichtinger-Schepman AM; Scheper RJ; de Vries EG
    Cancer Res; 1988 Dec; 48(23):6803-7. PubMed ID: 2846161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.
    de Vries EG; Meijer C; Timmer-Bosscha H; Berendsen HH; de Leij L; Scheper RJ; Mulder NH
    Cancer Res; 1989 Aug; 49(15):4175-8. PubMed ID: 2545337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
    Sinha BK; Mimnaugh EG; Rajagopalan S; Myers CE
    Cancer Res; 1989 Jul; 49(14):3844-8. PubMed ID: 2544260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
    Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of chemoresistance for the herpes simplex virus thymidine kinase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model.
    Van Dillen IJ; Mulder NH; Sluiter WJ; Meijer C; De Jong S; Loncarek J; Mesnil M; De Vries EF; Vaalburg W; Hospers GA
    Anticancer Res; 2005; 25(1A):255-61. PubMed ID: 15816546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells.
    Yang LY; Trujillo JM; Su YZ
    Anticancer Res; 1992; 12(2):473-9. PubMed ID: 1349796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced damage to DNA in drug- and radiation-resistant sublines of a human breast cancer cell line.
    Alaoui-Jamali MA; Batist G; Lehnert S
    Radiat Res; 1992 Jan; 129(1):37-42. PubMed ID: 1728055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A; Cohen L; Glaubiger D
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
    Mimnaugh EG; Dusre L; Atwell J; Myers CE
    Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.
    de Jong S; Mulder NH; de Vries EG; Robillard GT
    Br J Cancer; 1991 Feb; 63(2):205-12. PubMed ID: 1847646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of endogenous glutathione, superoxide dismutases, catalase, and glutathione peroxidase on adriamycin tolerance of Chinese hamster ovary cells.
    Keizer HG; van Rijn J; Pinedo HM; Joenje H
    Cancer Res; 1988 Aug; 48(16):4493-7. PubMed ID: 3396001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B; McCauley MD; Safa AR
    Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.